SEARCH

SEARCH BY CITATION

References

  • Al-Regaiey K. A., Masternak M. M., Bonkowski M., Sun L. and Bartke A. (2005) Long-lived growth hormone receptor knockout mice: interaction of reduced insulin-like growth factor i/insulin signaling and caloric restriction. Endocrinology 146, 851860.
  • Anandatheerthavarada H. K., Biswas G., Robin M. A. and Avadhani N. G. (2003) Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells. J. Cell Biol. 161, 4154.
  • Anekonda T. S. and Reddy P. H. (2005) Can plants provide a new generation of drugs for treating alzheimer's disease? Brain. Res. Rev., in press.
  • Anson R. M., Guo Z., De Cabo R., Iyun T., Rios M., Hagepanos A., Ingram D. K., Lane M. A. and Mattson M. P. (2003) Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake. Proc. Natl Acad. Sci. USA 100, 62166220.
  • Araki T., Sasaki Y., Milbrandt J. (2004) Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305, 10101013.
  • Bae N. S., Swanson M. J., Vassilev A. and Howard B. H. (2004) Human histone deacetylase SIRT2 interacts with the homeobox transcription factor HOXA10. J. Biochem. (Tokyo) 135, 695700.
  • Balaban R. S., Nemoto S. and Finkel T. (2005) Mitochondria, oxidants, and aging. Cell 120, 483495.
  • Barthelemy C., Henderson C. E. and Pettmann B. (2004) Foxo3a induces motoneuron death through the Fas pathway in cooperation with JNK. BMC Neurosci. 5, 48.
  • Bellizzi D., Rose G., Cavalcante P. et al. (2005) A novel VNTR enhancer within the SIRT3 gene, a human homologue of SIR2, is associated with survival at oldest ages. Genomics 85, 258263.
  • Billings L. M., Oddo S., Green K. N., McGaugh J. L. and Laferla F. M. (2005) Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 45, 675688.
  • Blander G. and Guarente L. (2004) The Sir2 family of protein deacetylases. Annu. Rev. Biochem. 73, 417435.
  • Bordone L. and Guarente L. (2005) Calorie restriction, SIRT1 and metabolism: understanding longevity. Nat. Rev. Mol. Cell. Biol. 6, 298305.
  • Brunet A., Sweeney L. B., Sturgill J. F. et al. (2004) Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303, 20112015.
  • Cheng H. L., Mostoslavsky R., Saito S., Manis J. P., Gu Y., Patel P., Bronson R., Appella E., Alt F. W. and Chua K. F. (2003) Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc. Natl Acad. Sci. USA 100, 10 79410 799.
  • Cohen H. Y., Miller C., Bitterman K. J., Wall N. R., Hekking B., Kessler B., Howitz K. T., Gorospe M., De Cabo R. and Sinclair D. A. (2004) Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305, 390392.
  • Culmsee C. and Mattson M. P. (2005) p53 in neuronal apoptosis. Biochem. Biophys. Res. Commun. 331, 761777.
  • Denu J. M. (2003) Linking chromatin function with metabolic networks: Sir2 family of NAD(C)-dependent deacetylases. Trends Biochem. Sci. 28, 4148.
  • Dillin A., Crawford D. K. and Kenyon C. (2002) Timing requirements for insulin/IGF-1 signaling in C. elegans. Science 298, 830834.
  • Dryden S. C., Nahhas F. A., Nowak J. E., Goustin A. S. and Tainsky M. A. (2003) Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle. Mol. Cell. Biol. 23, 31733185.
  • Duncan A. M., Phipps W. R. and Kurzer M. S. (2003) Phyto-oestrogens. Best Pract. Res. Clin. Endocrinol. Metab. 17, 253271.
  • Frye R. A. (1999) Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. Biochem. Biophys. Res. Commun. 260, 273279.
  • Frye R. A. (2000) Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem. Biophys. Res. Commun. 273, 793798.
  • Gasparini L. and Xu H. (2003) Potential roles of insulin and IGF-1 in Alzheimer's disease. Trends Neurosci. 26, 404406.
  • Getchell M. L., Shah D. S., Buch S. K., Davis D. G. and Getchell T. V. (2003) 3-Nitrotyrosine immunoreactivity in olfactory receptor neurons of patients with Alzheimer's disease: implications for impaired odor sensitivity. Neurobiol. Aging 24, 663673.
  • Gilley J., Coffer P. J. and Ham J. (2003) FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons. J. Cell Biol. 162, 613622.
  • Guarente L. (2000) Sir2 links chromatin silencing, metabolism, and aging. Genes Dev. 14, 10211026.
  • Guarente L. and Picard F. (2005) Calorie restriction – the SIR2 connection. Cell 120, 473482.
  • Hadley E. C., Lakatta E. G., Morrison-Bogorad M., Warner H. R. and Hodes R. J. (2005) The future of aging therapies. Cell 120, 557567.
  • Hekimi S. and Guarente L. (2003) Genetics and the specificity of the aging process. Science 299, 13511354.
  • Holzenberger M., Dupont J., Ducos B., Leneuve P., Geloen A., Even P. C., Cervera P. and Le Bouc Y. (2003) IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421, 182187.
  • Howitz K. T., Bitterman K. J., Cohen H. Y. et al. (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425, 191196.
  • Imai S., Armstrong C. M., Kaeberlein M. and Guarente L. (2000) Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403, 795800.
  • Jang J. H. and Surh Y. J. (2003) Protective effect of resveratrol on beta-amyloid-induced oxidative PC12 cell death. Free Radic. Biol. Med. 34, 11001110.
  • Kenyon C. (2005) The plasticity of aging: insights from long-lived mutants. Cell 120, 449460.
  • Kuzmichev A., Margueron R., Vaquero A. et al. (2005) Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation. Proc. Natl Acad. Sci. USA 102, 18591864.
  • Lamming D. W., Wood J. G. and Sinclair D. A. (2004) Small molecules that regulate lifespan: evidence for xenohormesis. Mol. Microbiol. 53, 10031009.
  • Langley E., Pearson M., Faretta M., Bauer U. M., Frye R. A., Minucci S., Pelicci P. G. and Kouzarides T. (2002) Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J. 21, 23832396.
  • Liszt G., Ford E., Kurtev M. and Guarente L. (2005) Mouse Sir2 homolog SIRT6 is a nuclear ADP-ribosyltransferase. J. Biol Chem. 280, 21 31321 320.
  • Luchsinger J. A. and Mayeux R. (2004) Dietary factors and Alzheimer's disease. Lancet Neurol. 3, 579587.
  • Lustbader J. W., Cirilli M., Lin C. et al. (2004) ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 304, 448452.
  • Manczak M., Park B. S., Jung Y. and Reddy P. H. (2004) Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage. Neuromol. Med. 5, 147162.
  • Maswood N., Young J., Tilmont E. et al. (2004) Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease. Proc. Natl Acad. Sci. USA 101, 18 17118 176.
  • Mattson M. P. (2003) Methylation and acetylation in nervous system development and nuerodegenerative disorders. Ageing Res. Rev. 2, 329342.
  • Mattson M. P., Duan W. and Guo Z. (2003) Meal size and frequency affect neuronal plasticity and vulnerability to disease: cellular and molecular mechanisms. J. Neurochem. 84, 417431.
  • McBurney M. W., Yang X., Jardine K., Hixon M., Boekelheide K., Webb J. R., Lansdorp P. M. and Lemieux M. (2003) The mammalian SIR2alpha protein has a role in embryogenesis and gametogenesis. Mol. Cell. Biol. 23, 3854.
  • De La Monte S. M. and Wands J. R. (2004) Alzheimer-associated neuronal thread protein mediated cell death is linked to impaired insulin signaling. J. Alzheimers Dis. 6, 231242.
  • Morales M. and Fifkova E. (1991) Distribution of acetylated alpha-tubulin in brain. In situ localization and biochemical characterization. Cell Tissue Res. 265, 415423.
  • Motta M. C., Divecha N., Lemieux M., Kamel C., Chen D., Gu W., Bultsma Y., McBurney M. and Guarente L. (2004) Mammalian SIRT1 represses forkhead transcription factors. Cell 116, 551563.
  • Muth V., Nadaud S., Grummt I. and Voit R. (2001) Acetylation of TAF(I)68, a subunit of TIF-IB/SL1, activates RNA polymerase I transcription. EMBO J. 20, 13531362.
  • Nemoto S., Fergusson M. M. and Finkel T. (2004) Nutrient availability regulates SIRT1 through a forkhead-dependent pathway. Science 306, 21052108.
  • Nemoto S., Fergusson M. M. and Finkel T. (2005) SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1α. J. Biol. Chem. 280, 16 45616 460.
  • Nijveldt R. J., Van Nood E., Van Hoorn D. E., Boelens P. G., Van Norren K. and Van Leeuwen P. A. (2001) Flavonoids: a review of probable mechanisms of action and potential applications. Am. J. Clin. Nutr. 74, 418425.
  • North B. J. and Verdin E. (2005) Sirtuins: Sir2-related NAD-dependent protein deacetylates. Genome Biol. 5, 224.
  • North B. J., Marshall B. L., Borra M. T., Denu J. M. and Verdin E. (2003) The human Sir2 ortholog, SIRT2, is an NAD+ dependent tubulin deacetylase. Mol. Cell 11, 437444.
  • Ohyagi Y., Asahara H., Chui D. H. et al. (2005) Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease. FASEB J. 19, 255257.
  • Onyango P., Celic I., McCaffery J. M., Boeke J. D. and Feinberg A. P. (2002) SIRT3, a human SIR2 homologue, is an NAD-dependent deacetylase localized to mitochondria. Proc. Natl Acad. Sci. USA 99, 13 65313 658.
  • Pagans S., Pedal A., North B. J. et al. (2005) SIRT1 regulates HIV transcription via Tat deacetylation. PLoS Biol. 3, e41.
  • Panza F., Solfrizzi V., Colacicco A. M., D'Introno A., Capurso C., Torres F., Del Parigi A., Capurso S. and Capurso A. (2004) Mediterranean diet and cognitive decline. Public Health Nutr. 7, 959963.
  • Parker J. A., Arango M., Abderrahmane S., Lambert E., Tourette C., Catoire H. and Neri C. (2005) Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Nat Genet. 37, 349350. Erratum: Nat. Genet. 37, 555.
  • Patel N. V., Gordon M. N., Connor K. E., Good R. A., Engelman R. W., Mason J., Morgan D. G., Morgan T. E. and Finch C. E. (2005) Caloric restriction attenuates Abeta-deposition in Alzheimer transgenic models. Neurobiol. Aging 26, 9951000.
  • Picard F., Kurtev M., Chung N., Topark-Ngarm A., Senawong T., Machado De Oliveira R., Leid M., McBurney M. W. and Guarente L. (2004) Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 429, 771776. Erratum: Nature430, 921.
  • Poole C. A., Zhang Z. J. and Ross J. M. (2001) The differential distribution of acetylated and detyrosinated alpha-tubulin in the microtubular cytoskeleton and primary cilia of hyaline cartilage chondrocytes. J. Anat. 199, 393405.
  • Porcu M. and Chiarugi A. (2005) The emerging therapeutic potential of sirtuin-interacting drugs: from cell death to lifespan extension. Trends Pharmacol. Sci. 26, 94103.
  • Reddy P. H. and Beal M. F. (2005) Are mitochondria critical in the pathogenesis of Alzheimer's disease? Brain Res. Rev. in press .
  • Reddy P. H. and McWeeney S. (2005) Mapping cellular transcriptosomes in autopsied Alzheimer's disease subjects and relevant mouse models. Neurobiol. Aging in press .
  • Reddy P. H., McWeeney S., Park B. S. et al. (2004) Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease. Hum. Mol. Genet. 13, 12251240.
  • Rodgers J. T., Lerin C., Haas W., Gygi S. P., Spiegelman B. M. and Puigserver P. (2005) Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434, 113118.
  • Rose G., Dato S., Altomare K. et al. (2003) Variability of the SIRT3 gene, human silent information regulator Sir2 homologue, and survivorship in the elderly. Exp. Gerontol. 38, 10651070.
  • Russo A., Palumbo M., Aliano C., Lempereur L., Scoto G. and Renis M. (2003) Red wine micronutrients as protective agents in Alzheimer-like induced insult. Life Sci. 72, 23692379.
  • Savaskan E., Olivieri G., Meier F., Seifritz E., Wirz-Justice A. and Muller-Spahn F. (2003) Red wine ingredient resveratrol protects from beta-amyloid neurotoxicity. Gerontology 49, 380383.
  • Schriner S. E., Linford N. J., Martin G. M. et al. (2005) Extension of murine lifespan by overexpression of catalase targeted to mitochondria. Science 308, 19091911.
  • Schwer B., North B. J., Frye R. A., Ott M. and Verdin E. (2002) The human silent information regulator (Sir) 2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase. J. Cell Biol. 158, 647657.
  • Selkoe D. J. (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81, 741766.
  • Selkoe D. J. (2002) Alzheimer's disease is a synaptic failure. Science 298, 789791.
  • Senawong T., Peterson V. J., Avram D., Shepherd D. M., Frye R. A., Minucci S. and Leid M. (2003) Involvement of the histone deacetylase SIRT1 in chicken ovalbumin upstream promoter transcription factor (COUP-TF)-interacting protein 2-mediated transcriptional repression. J. Biol. Chem. 278, 43 04143 050.
  • Senawong T., Peterson V. J. and Leid M. (2005) BCL11A-dependent recruitment of SIRT1 to a promoter template in mammalian cells results in histone deacetylation and transcriptional repression. Arch. Biochem. Biophys. 434, 316325.
  • Sharma M. and Gupta Y. K. (2002) Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats. Life Sci. 71, 24892498.
  • Shi T., Wang F., Stieren E. and Tong Q. (2005) SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes. J. Biol. Chem. 280, 13 56013 567.
  • Sinclair D. Sirtuins for healthy neurons. Nat Genet. 37, 339340. (2005)
  • Stokin G. B., Lillo C., Falzone T. L. et al. (2005) Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 307, 12821288.
  • Takata T. and Ishikawa F. (2003) Human Sir2-related protein SIRT1 associates with the bHLH repressors HES1 and HEY2 and is involved in HES1- and HEY2-mediated transcriptional repression. Biochem. Biophys. Res. Commun. 301, 250257.
  • Tamagno E., Bardini P., Obbili A. et al. (2002) Oxidative stress increases expression and activity of BACE in NT2 neurons. Neurobiol. Dis. 10, 279288.
  • Tamagno E., Guglielmotto M., Bardini P., Santoro G., Davit A., Di Simone D., Danni O. and Tabaton M. (2003) Dehydroepiandrosterone reduces expression and activity of BACE in NT2 neurons exposed to oxidative stress. Neurobiol. Dis. 14, 291301.
  • Tamagno E., Parola M., Bardini P. et al. (2005) Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. J. Neurochem. 92, 628636.
  • Tang B. L. (2005a) SIRT1, neuronal cell survival and insulin/IGF-1 aging paradox. Neurobiol. Aging in press:.
  • Tang B. L. (2005b) Alzheimer's disease: channeling APP to non-amyloidogenic processing. Biochem. Biophys. Res. Commun. 331, 375358.
  • Tatar M., Bartke A. and Antebi A. (2003) The endocrine regulation of aging by insulin-like signals. Science 299, 13461351.
  • Tissenbaum H. A. and Guarente L. (2001) Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 410, 227230.
  • Vaquero A., Scher M., Lee D., Erdjument-Bromage H., Tempst P. and Reinberg D. (2004) Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin. Mol. Cell 16, 93105.
  • Vaziri H., Dessain S. K., Ng Eaton E., Imai S. I., Frye R. A., Pandita T. K., Guarente L. and Weinberg R. A. (2001) hSIR2 (SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107, 149159.
  • Williams R. J., Spencer J. P. and Rice-Evans C. (2004) Flavonoids: antioxidants or signalling molecules? Free Radic. Biol. Med. 36, 838849.
  • Wood J. G., Rogina B., Lavu S., HowitZ. K., Helfand S. L., Tatar M. and Sinclair D. (2004) Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430, 686689. Erratum: Nature431, 107.
  • Yang Y., Hou H., Haller E. M., Nicosia S. V. and Bai W. (2005) Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation. EMBO J. 24, 10211032.
  • Yeung F., Hoberg J. E., Ramsey C. S., Keller M. D., Jones D. R., Frye R. A. and Mayo M. W. (2004) Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 23, 23692380.
  • You H. and Mak T. W. (2005) Crosstalk between p53 and FOXO transcription factors. Cell Cycle 4, 3738.
  • Yu T. T., McIntyre J. C., Bose S. C., Hardin D., Owen M. C. and McClintock T. S. (2005) Differentially expressed transcripts from phenotypically identified olfactory sensory neurons. J. Comp. Neurol. 483, 251262.